Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 5/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MME | P08473 | 3/20 | 0.48 |
| ▸ | CTSK | P43235 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 2/20 | 0.47 |
| ▸ | CPA1 | P15085 | 2/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28122659 | 1.00 | CTSC (0.68) | CTSCLMNATDP1HTR2CHTR2B | |
| SCHEMBL601566 | 1.00 | CTSC (0.68) | CTSCLMNATDP1HTR2CHTR2B | |
| SCHEMBL21808154 | 1.00 | CTSC (0.68) | CTSCLMNATDP1HTR2CHTR2B | |
| SCHEMBL3008134 | 1.00 | CTSC (0.68) | CTSCLMNATDP1HTR2CHTR2B | |
| SCHEMBL11187709 | 1.00 | CTSC (0.68) | CTSCLMNATDP1HTR2CHTR2B | |
| SCHEMBL28122660 | 1.00 | CTSC (0.68) | CTSCLMNATDP1HTR2CHTR2B | |
| SCHEMBL31026629 | 1.00 | CTSC (0.68) | CTSCLMNATDP1HTR2CHTR2B | |
| SCHEMBL29413816 | 0.96 | CTSC (0.64) | CTSCLMNATDP1ALDH1A1HSD17B10 | |
| SCHEMBL30015836 | 0.96 | CTSC (0.64) | CTSCLMNATDP1ALDH1A1HSD17B10 | |
| SCHEMBL30546877 | 0.95 | CTSC (0.63) | CTSCLMNATDP1HTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12426782-B2 | Systems and temporal alignment methods for evaluation of gestational age and time to delivery | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-09-30 | — | — | US | claimed |
| US-12377110-B2 | Fospropofol methods and compositions | EPALEX CORPORATION (US) | 2025-08-05 | — | — | US | claimed |
| CN-120148690-A | Preparation method and application of fermented soybean containing bioactive peptide | 澳门科技大学 | 2025-06-13 | — | — | CN | claimed |
| CN-119875976-A | Breeding strain for producing gellan gum and method for producing gellan gum by using strain fermentation method | 江南大学 | 2025-04-25 | — | — | CN | claimed |
| CN-119859167-A | Preparation method of ISARIDIN E cyclic ester peptide | 中山大学 | 2025-04-22 | — | — | CN | claimed |
| CN-119224161-A | Method for detecting various dipeptides in rumen fluid of ruminant | 中国科学院亚热带农业生态研究所 | 2024-12-31 | — | — | CN | claimed |
| CN-118425362-B | Organic acid metabolism marker for distinguishing wild and cultivated four-big domestic fish and application thereof | 中国水产科学研究院长江水产研究所 | 2024-12-10 | — | — | CN | claimed |
| CN-118501300-B | Method for detecting total content of proline or hydroxyproline dipeptide in collagen peptide | 中国海洋大学三亚海洋研究院 | 2024-10-11 | — | — | CN | claimed |
| US-20240315296-A1 | PEPTIDE COMPOUNDS FOR FLAVOR MODULATING | CJ CHEILJEDANG CORPORATION (KR) | 2024-09-26 | — | — | US | claimed |
| CN-118660707-A | Supermolecule self-assembly system | 北京睿创康泰医药研究院有限公司 | 2024-09-17 | — | — | CN | claimed |
| US-20220105050-A1 | PROPOFOL PRODRUG METHODS AND COMPOSITIONS | EPALEX CORPORATION | 2022-04-07 | — | — | US | claimed |
| EP-3853613-A1 | METHODS FOR EVALUATION OF GESTATIONAL PROGRESS AND PRETERM ABORTION FOR CLINICAL INTERVENTION AND APPLICATIONS THEREOF | The Board of Trustees of the Leland Stanford Junior University (US) | 2021-07-28 | — | — | EP | claimed |
| WO-2020061590-A1 | METHODS FOR EVALUATION OF GESTATIONAL PROGRESS AND PRETERM ABORTION FOR CLINICAL INTERVENTION AND APPLICATIONS THEREOF | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2020-03-26 | — | — | WO | claimed |
| CN-102348693-A | Methods for preparing JAK inhibitors and related intermediate compounds | INCYTE CORP | 2012-02-08 | — | — | CN | claimed |
| EP-2398774-A2 | PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS | Incyte Corporation (US) | 2011-12-28 | — | — | EP | claimed |
| US-20100190981-A1 | PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS | INCYTE CORPORATION | 2010-07-29 | — | — | US | claimed |
| WO-2010083283-A2 | PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS | INCYTE CORPORATION (US) | 2010-07-22 | — | — | WO | claimed |
| EP-0197794-B1 | PREPARATION OF PEPTIDES WITH C-TERMINAL PROLINE AMIDE | SANKYO COMPANY LIMITED (JP) | 1989-12-13 | — | — | EP | claimed |
| US-4709014-A | Preparation of peptides with C-terminal proline amide | SANKYO COMPANY LIMITED (JP) | 1987-11-24 | — | — | US | claimed |
| EP-0197794-A2 | Preparation of peptides with C-terminal proline amide | SANKYO COMPANY LIMITED (JP) | 1986-10-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190981-A1 | PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS | JAK3, JAK1, JAK2 | CTSC 2746/4885LMNA 4322/4885TDP1 2955/4885 |
| US-12377110-B2 | Fospropofol methods and compositions | FOS, FOSB, PFAS | CTSC 2217/4885LMNA 2765/4885TDP1 686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.